Cracking Cancer 2.0 - Lightning Talks

Startup Exchange Video | Duration: 30:06
December 7, 2017
Cracking Cancer 2.0 - Lightning Talks
Please login to view this video.
Locked Interactive transcript
  • Video details

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange

    • A new approach to personalized medicine for cancer, Cliff Reid, PhD, CEO, Travera.
    • Supercharged single-cell profiling tech, Todd Gierahn, PhD, Cofounder, Honeycomb. 
    • Drug-eluting platform technology cracking solid tumors, Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics, TED Fellow, Entrepreneur in Residence at MGH Cancer Center, Postdoctoral Associate with Professors Elazer Edelman and Robert Langer, MIT.
    • Cancer immunotherapy 2.0: tackling hostile tumors, Ulrik B. Nielsen, PhD, CEO & Cofounder, Torque.
    • Applying rocket science to biotechnology, Jason Norris, Cofounder, Elektrofi. 
    • Harnessing cell death to drive immunity, Patrick Stern, PhD, CEO & Founder, Sextant
    • Non-invasive white cells monitoring device for chemo patients, Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs
    • Programming living cells using genetic circuits, Alec Nielsen, PhD, Cofounder, Asimov.
Cracking Cancer 2.0 - Lightning Talks
Please login to view this video.
Locked Interactive transcript
  • Video details

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange

    • A new approach to personalized medicine for cancer, Cliff Reid, PhD, CEO, Travera.
    • Supercharged single-cell profiling tech, Todd Gierahn, PhD, Cofounder, Honeycomb. 
    • Drug-eluting platform technology cracking solid tumors, Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics, TED Fellow, Entrepreneur in Residence at MGH Cancer Center, Postdoctoral Associate with Professors Elazer Edelman and Robert Langer, MIT.
    • Cancer immunotherapy 2.0: tackling hostile tumors, Ulrik B. Nielsen, PhD, CEO & Cofounder, Torque.
    • Applying rocket science to biotechnology, Jason Norris, Cofounder, Elektrofi. 
    • Harnessing cell death to drive immunity, Patrick Stern, PhD, CEO & Founder, Sextant
    • Non-invasive white cells monitoring device for chemo patients, Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs
    • Programming living cells using genetic circuits, Alec Nielsen, PhD, Cofounder, Asimov.